CINECA IRIS Institutional Research Information System

ROCCATELLO, Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.626
EU - Europa 27.393
AS - Asia 17.326
SA - Sud America 3.757
AF - Africa 564
OC - Oceania 535
Continente sconosciuto - Info sul continente non disponibili 66
Totale 83.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.919
IT - Italia 7.771
CN - Cina 7.730
FR - Francia 2.769
JP - Giappone 2.557
ES - Italia 2.438
DE - Germania 2.206
IE - Irlanda 2.042
GB - Regno Unito 1.745
SG - Singapore 1.711
MX - Messico 1.585
SE - Svezia 1.582
UA - Ucraina 1.240
BR - Brasile 1.199
FI - Finlandia 1.030
KR - Corea 994
CA - Canada 936
IN - India 875
CO - Colombia 854
AR - Argentina 757
PL - Polonia 724
TR - Turchia 605
NL - Olanda 531
VN - Vietnam 522
RU - Federazione Russa 494
AU - Australia 487
CH - Svizzera 394
TW - Taiwan 385
GR - Grecia 367
ID - Indonesia 338
CL - Cile 337
BE - Belgio 332
PT - Portogallo 300
TH - Thailandia 283
AT - Austria 277
RO - Romania 268
HK - Hong Kong 259
PE - Perù 250
IL - Israele 248
EC - Ecuador 175
SA - Arabia Saudita 155
DK - Danimarca 126
EG - Egitto 118
IR - Iran 104
HU - Ungheria 100
CZ - Repubblica Ceca 99
RS - Serbia 96
TN - Tunisia 93
VE - Venezuela 92
PH - Filippine 87
NO - Norvegia 86
MA - Marocco 85
SI - Slovenia 81
HR - Croazia 80
MY - Malesia 73
DZ - Algeria 62
PK - Pakistan 56
EU - Europa 55
ZA - Sudafrica 50
NZ - Nuova Zelanda 45
UY - Uruguay 41
CR - Costa Rica 39
AE - Emirati Arabi Uniti 37
BG - Bulgaria 36
IQ - Iraq 33
PS - Palestinian Territory 33
BO - Bolivia 32
RE - Reunion 31
SK - Slovacchia (Repubblica Slovacca) 30
PA - Panama 28
GT - Guatemala 25
MU - Mauritius 25
CY - Cipro 23
NP - Nepal 23
BY - Bielorussia 21
EE - Estonia 21
NI - Nicaragua 21
UZ - Uzbekistan 21
BD - Bangladesh 20
QA - Qatar 20
NG - Nigeria 19
DO - Repubblica Dominicana 18
LB - Libano 18
KW - Kuwait 17
LT - Lituania 17
MT - Malta 17
PY - Paraguay 16
SV - El Salvador 16
JO - Giordania 13
MD - Moldavia 13
GE - Georgia 12
LV - Lettonia 12
OM - Oman 11
AL - Albania 10
CU - Cuba 10
KE - Kenya 10
LK - Sri Lanka 10
BA - Bosnia-Erzegovina 9
ET - Etiopia 9
MK - Macedonia 9
Totale 83.085
Salva come PNG Salva come JPEG
Città #
Beijing 2.796
Chandler 2.053
Dublin 1.965
Redwood City 1.898
Santa Clara 1.898
Fairfield 1.545
Houston 1.528
Ann Arbor 1.342
Singapore 1.272
Wilmington 931
Torino 914
Ashburn 894
Jacksonville 881
Villeurbanne 820
Woodbridge 807
Seattle 660
Medford 659
Dearborn 657
Tokyo 654
Milan 630
Princeton 609
Columbus 566
Shanghai 563
Cambridge 526
Turin 481
Warsaw 459
Guangzhou 452
Pisa 400
Madrid 370
Nyköping 353
Rome 353
Bogotá 327
Paris 309
New York 289
Barcelona 282
Dong Ket 277
Buenos Aires 275
Nanjing 268
Santiago 266
São Paulo 255
Hangzhou 244
Boston 243
Jakarta 240
Taipei 203
Chengdu 196
Fremont 190
Mexico City 188
Lima 186
Helsinki 183
London 182
Mexico 181
Medellín 178
Chicago 170
Wuhan 164
Zhengzhou 163
Toronto 162
Vienna 162
Sesto San Giovanni 152
Istanbul 148
Verona 140
Osaka 135
Bangkok 133
Bologna 130
Munich 130
Los Angeles 129
San Diego 129
Athens 122
Boardman 121
Jinan 120
Changsha 119
Florence 116
Hefei 112
Guadalajara 111
Rochester 109
Valencia 103
Norwalk 101
Berlin 99
Ottawa 98
Hebei 97
Munro 96
Brussels 93
Seoul 90
Padova 88
Lubbock 86
Ankara 85
Córdoba 82
Quito 81
Moscow 80
Montréal 78
Sydney 77
Chongqing 76
Hong Kong 75
Cuauhtémoc 74
Philadelphia 72
Duncan 71
Falls Church 71
Tianjin 71
Fuzhou 70
Shenyang 70
Hanoi 69
Totale 40.028
Salva come PNG Salva come JPEG
Nome #
Cryoglobulinaemia 6.057
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances 3.422
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2.165
GAPSS: the Global Anti-Phospholipid Syndrome Score. 2.138
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature 1.526
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. 1.384
Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review 1.338
Renal involvement in antiphospholipid syndrome. 1.164
Acute renal infarction: a single center experience 1.132
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.041
Acute kidney injury associated with glomerular diseases 1.033
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. 1.020
Antiphospholipid Syndrome and the Kidney 886
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. 882
IgG4-related nephropathy 845
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment 814
Radiotherapy in patients with connective tissue diseases 813
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. 702
[Extracorporeal therapy in sepsis] 660
Dealing with stuck hemodialysis catheter: state of the art and tips for the nephrologist. 654
The global anti-phospholipid syndrome score in primary APS. 597
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome 594
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 563
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. 554
Catastrophic antiphospholipid syndrome (CAPS). 550
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence 533
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 528
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 524
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 524
Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review 512
Rheumatoid arthritis: Biological therapy other than anti-TNF 502
Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review 485
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 479
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome 471
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 470
Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials 470
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 461
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein) 457
Pregnancy outcomes in mixed connective tissue disease: a multicentre study 442
Living With and Treating Rare Diseases: Experiences of Patients and Professional Health Care Providers 426
Anticorpi anti-GM1 ed anti-solfatidi nelle vasculiti sistemiche primitive e secondarie 412
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 410
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: A pooled analysis 409
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 407
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 406
Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. 393
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 360
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab 359
Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. 352
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 338
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies 336
Radiotherapy in patients with HIV: current issues and review of the literature 330
Nemo syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association. 329
Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target? 329
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 326
Venous Window Needle Guide for deep vessels and difficult arteriovenous fistula cannulation 319
The risk of ischaemic stroke in primary APS patients: a prospective study 309
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 304
Treatment of antiphospholipid syndrome 298
Upcoming biological therapies in systemic lupus erythematosus. 289
Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. 289
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 281
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 276
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 268
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. 259
The dilemma of treating hepatitis C virus-associated cryoglobulinemia 257
Fagocitosi monocitaria frusta di crioglobuline in pazienti con nefrite crioglobulinemica 252
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study) 251
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome 250
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome 245
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 241
"How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis 238
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 236
How I treat patients with systemic sclerosis in clinical practice 219
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 218
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome. 216
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets 211
Rituximab in cryoglobulinemic peripheral neuropathy 206
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 205
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 204
The Case | the young philosopher with multiple sclerosis and proteinuria 203
Trasporto e smaltimento degli immunocomplessi circolanti nelle glomerulonefriti umane 196
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 189
Lab-on-a-chip: Emerging analytical platforms for immune-mediated diseases. 189
Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome. 189
Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. 187
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 185
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 183
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 183
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score 178
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study 175
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 174
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab 173
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 168
Antiphospholipid antibodies: crossroads between autoimmunity and infections? 167
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 167
Standardized reporting of monoclonal immunoglobulin–associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group 164
An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis 163
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 161
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 160
Totale 55.209
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.890
article - articoli 0
book - libri 0
conference - conferenze 23.722
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 209.612
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.110 0 0 0 0 0 1.589 1.336 1.065 1.346 1.020 986 768
2020/202112.083 929 754 1.128 901 1.188 928 958 728 1.231 1.099 962 1.277
2021/202210.825 748 766 819 932 938 819 823 817 782 672 1.134 1.575
2022/202312.031 1.083 763 521 840 975 2.344 1.189 992 1.152 599 818 755
2023/20249.351 993 1.028 726 777 851 679 704 770 207 686 803 1.127
2024/20258.021 606 972 879 1.536 3.077 951 0 0 0 0 0 0
Totale 86.046